The price of Bristol-Myers Squibb Co (NYSE:BMY) shares last traded on Wall Street rose 0.90% to $55.95.
BMY stock price is now 8.59% away from the 50-day moving average and 16.55% away from the 200-day moving average. The market capitalization of the company currently stands at $113.48B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $75 to $55, Citigroup Downgraded its rating from Buy to Neutral for Bristol-Myers Squibb Co (NYSE: BMY). On October 17, 2024, Bernstein recently initiated its ‘Mkt Perform’ rating on the stock quoting a target price of $56, while ‘Barclays’ rates the stock as ‘Equal Weight’
In other news, Holzer Phil M, SVP and Controller sold 700 shares of the company’s stock on Nov 04 ’24. The stock was sold for $38,930 at an average price of $55.62. Upon completion of the transaction, the SVP and Controller now directly owns 11,760 shares in the company, valued at $0.66 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 01 ’24, EVP,Chief Med.Offr.,Drug Dev. Hirawat Samit bought 1,830 shares of the business’s stock. A total of $100,055 was incurred on buying the stock at an average price of $54.67. This leaves the insider owning 62,109 shares of the company worth $3.47 million. A total of 0.08% of the company’s stock is owned by insiders.
During the past 12 months, Bristol-Myers Squibb Co has had a low of $39.35 and a high of $56.20. As of last week, the company has a debt-to-equity ratio of 3.00, a current ratio of 1.24, and a quick ratio of 1.09. The fifty day moving average price for BMY is $51.3718 and a two-hundred day moving average price translates $47.97185 for the stock.
The latest earnings results from Bristol-Myers Squibb Co (NYSE: BMY) was released for 2024-09-30. The net profit margin was -15.30% and return on equity was -31.46% for BMY. The company reported revenue of $11.89 billion for the quarter, compared to $10.97 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.44 percent.
